![Neurotechnology: A Giving Smarter Guide](/sites/default/files/styles/search_thumbnail/public/2021-10/Cover-Neurotechnology.jpg?itok=PxOAAkMo)
Neurotechnology: A Giving Smarter Guide
![Request for Proposals: Misophonia](/sites/default/files/styles/search_thumbnail/public/2022-06/Misophonia%20Reserch%20Fund%20RFP%20Image.png?itok=LnSZwUwz)
Request for Proposals: Misophonia
![The Emergence of New Monies and the Need to Prepare the Financial System for the Digital Age](/sites/default/files/styles/search_thumbnail/public/2021-09/The%20Emergence%20of%20New%20Monies.png?itok=f9N_9NXO)
The Emergence of New Monies and the Need to Prepare the Financial System for the Digital Age
![Ensuring ESG Impact: Four Actionable Recommendations for a Dependable Path | Milken Institute](/sites/default/files/styles/search_thumbnail/public/2021-09/Ensuring%20ESG%20Impact_t20.png?itok=Vyk6E9qV)
Ensuring ESG Impact: Four Actionable Recommendations for a Dependable Path | Milken Institute
![Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project](/sites/default/files/styles/search_thumbnail/public/2021-09/MicrosoftTeams-image%20%2892%29.png?itok=yuqqrxM6)
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
![Building Resilience: Cloud Adoption in Southeast Asia's Financial Sector](/sites/default/files/styles/search_thumbnail/public/2021-09/MicrosoftTeams-image%20%2887%29.png?itok=5PerpwyF)
Building Resilience: Cloud Adoption in Southeast Asia's Financial Sector
![Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions](/sites/default/files/oembed_thumbnails/JlLfWoG6g3_Hn-6oojseDzZVHbuvbXGR9leDf91hzyA.jpg)
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions
![Dec. 7 at 4:30 pm ET | Is Digital Health a Bridge to Health Equity and Representation?](/sites/default/files/oembed_thumbnails/dEo6YmV-dTUReJPHodu4AMXDxQzl2fD2HixmowKYrz0.jpg)
Dec. 7 at 4:30 pm ET | Is Digital Health a Bridge to Health Equity and Representation?
![Dec. 7 at 4:30 pm ET | The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health](/sites/default/files/oembed_thumbnails/WV-DfpXQJDoQ-F6iVx6zpjHjo5TZs5uUd8yDTgq3tA4.jpg)
Dec. 7 at 4:30 pm ET | The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health
![Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock](/sites/default/files/oembed_thumbnails/rKmDUGuyj6bDsY0q4dbwSaOpSHKtESrqw8EfmPEsyeU.jpg)
Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock
![Dec. 7 at 2:30 pm ET | A Conversation with US Representatives Diana DeGette and Fred Upton on Cures 2.0 Legislation](/sites/default/files/oembed_thumbnails/SvlFtGvB5bPq9wCMqPh7UFBmt2_vuvdvT0H78THFTeQ.jpg)
Dec. 7 at 2:30 pm ET | A Conversation with US Representatives Diana DeGette and Fred Upton on Cures 2.0 Legislation
![Dec. 7 at 2:30 pm ET | The Road Ahead for Improving Access to Testing and Treatment for Rare Diseases](/sites/default/files/oembed_thumbnails/HdJdQqLDLzG8SvEWzamcEsV_e2WBHifpXiRu1SPGcoo.jpg)